Delivery Order 36C25524D0411-36C25524F0079
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to Sofie CO. (doing business as IBA Molecular) for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used for prostate cancer detection. The contract has a ceiling value of $1,172,834.00 and an ultimate completion date of May 31, 2026. Sofie CO. is a for-profit organization specializing in the development,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15, awarded a $252,750 firm fixed-price delivery order to Sofie CO. (doing business as IBA Molecular) on January 12, 2026, for PET-CT dose services at the Kansas City Veterans Affairs Medical Center. This delivery order is part of a larger indefinite delivery vehicle valued at $5.86 million for PYLARIFY F-18 DCFPYL, a positron emission tomography imaging agent used primarily for prostate cancer detection. The contract was...
- On March 1, 2024, the Department of Veterans Affairs, through Veterans Integrated Service Network 16, awarded a delivery order valued at $235,810.76 to Sofie CO. (doing business as IBA Molecular) for the supply of radioactive positron emission tomography (PET) tracer isotopes to the Medical Center at the Veterans Integrated Service Network 16. This firm-fixed-price delivery order represents pricing year one activity under Indefinite Delivery Contract 36C25624D0046 and is scheduled for completion...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 16 awarded a $339,600 delivery order to Sofie CO. (doing business as IBA Molecular) on January 22, 2026, for the procurement of radioactive isotopes and positron emission tomography (PET) tracers for the Michael E. DeBakey VA Medical Center in Sterling, Virginia. This is a firm fixed-price delivery order without set-aside designation, representing the third year of ordering under an existing indefinite delivery...
- The U.S. Department of Veterans Affairs (VA) awarded a $1,104,268.32 firm-fixed-price purchase order contract to Sofie CO., doing business as IBA Molecular, for the purchase and delivery of 450 doses of the radiopharmaceutical PYLARIFY. This contract, set aside for total small business, supports the VA's medical imaging and cancer treatment programs at its Washington, D.C. medical center. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular...
- This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
- The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
- This federal contract award, valued at $822,788.16, was issued by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular. The contract is a firm fixed-price purchase order for the radiopharmaceutical product PYLARIFY, which is used for prostate cancer detection. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a...
- The U.S. Department of Veterans Affairs (VA) awarded a $75,783.12 firm-fixed-price purchase order contract to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical used in prostate cancer detection. This contract is part of Sofie's broader supply of specialized imaging agents, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. Sofie has...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
- 36C25524D0411Indefinite Delivery Contract
- 36C25524D0411-36C25524F0079Delivery Order
Sofie CO., operating under the brand name IBA Molecular, received a delivery order award from Veterans Integrated Service Network 15 (VISN 15) on June 1, 2024, for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used in positron emission tomography (PET) imaging. The contract is structured as a firm fixed-price delivery order with a ceiling value of $1.35M and an ultimate completion date of May 31, 2025. This award carries no set-aside designation, reflecting the contractor's competitive market position in specialized radiopharmaceuticals. The place of performance is St. Louis, Missouri, with delivery to support VA medical facilities within VISN 15. This delivery order is issued under a larger Indefinite Delivery Vehicle (IDV) valued at $5.86M that Sofie CO. maintains with VISN 15 for PYLARIFY F-18 DCFPYL supply. Sofie CO., a subsidiary of Sofie Biosciences headquartered in Sterling, Virginia, specializes in developing and delivering molecular diagnostics and radiopharmaceuticals to federal healthcare agencies. PYLARIFY is a PET imaging agent designed for prostate cancer detection, representing critical diagnostic support for VA medical treatment facilities. The company maintains multiple federal contract vehicles with the Department of Veterans Affairs and Defense Health Agency, demonstrating its established role as a key supplier of specialized radiopharmaceuticals across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $180.4k | 12/9/25 | |
| Not listed | Not listed | $1.2m | 5/31/24 |